Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort (Q46463027)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 September 2012

Language	Label	Description	Also known as
English	Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort	scientific article published on 14 September 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

Susan M Gapstur

4

object named as

Susan M Gapstur

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

author name string

Lauren R Teras

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

Alpa V Patel

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

Janet S Hildebrand

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

publication date

14 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

54

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

720-725

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

The epidemiology of non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Sex hormones and the immune response in humans

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Sex hormones and the immune system--Part 2. Animal data

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Update in hormone therapy use in menopause

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Hormone replacement therapy and risk of lymphomas and myelomas

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Hormone replacement therapy and cancer risk: A systematic analysis from a network of case‐control studies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Oral contraceptives, menopausal hormone therapy use and risk of B-cell non-Hodgkin lymphoma in the California Teachers Study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Biological effects of hormone replacement therapy in relation to serum estradiol levels

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Estrogen as an immunomodulator

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.722216

21 January 2018

Identifiers

10.3109/10428194.2012.722216

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/22916741

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46463027&oldid=2112871935"